abrdn Life Sciences Investors - Common (HQL)

CUSIP: 87911K100

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / Common
Shares outstanding
29,948,325
Total 13F shares
2,565,495
Share change
+229,221
Total reported value
$43,758,000
Price per share
$16.99
Number of holders
44
Value change
+$3,771,229
Number of buys
29
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 87911K100?
CUSIP 87911K100 identifies HQL - abrdn Life Sciences Investors - Common in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of abrdn Life Sciences Investors - Common (HQL) as of Q4 2016

As of 31 Dec 2016, abrdn Life Sciences Investors - Common (HQL) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,565,495 shares. The largest 10 holders included MORGAN STANLEY, NEEDHAM INVESTMENT MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, FLAGSHIP HARBOR ADVISORS, LLC, CITIGROUP INC, LPL Financial LLC, RAYMOND JAMES & ASSOCIATES, BANK OF NOVA SCOTIA, UBS Group AG, and FIRST TRUST ADVISORS LP. This page lists 44 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.